Previous Section Back to Table of Contents Lords Hansard Home Page

Drug Tariff

Earl Howe asked Her Majesty's Government:

The Parliamentary Under-Secretary of State, Department of Health (Lord Darzi of Denham): The cost to date (end of August 2007) to carry out both phases of the review of the Arrangements under Part IX of the Drug Tariff is £1.9 million.

Phase 1 (Dressings and Reagents) was successfully implemented in October 2006 and savings of £24 million per annum are being achieved.

Phase 2 (Arrangements under Part IX of the Drug Tariff for the provision of stoma and incontinence appliances and related services) is currently subject to a public consultation which is anticipated to close on 28 December 2007.

It is not possible to forecast the total cost of the review at this stage.



17 Dec 2007 : Column WA96

Economic Partnership Agreements: ACP Countries

The Earl of Sandwich asked Her Majesty's Government:

The Parliamentary Under-Secretary of State, Department for International Development (Baroness Vadera): Economic partnership agreements—EPAs—can be good for development and help countries trade their way out of poverty. They will provide 100 per cent duty-free quota-free access to European Union (EU) markets, and more simple and liberal rules of origin that will make it easier for ACP countries to export goods.

African, Caribbean and Pacific (ACP) countries are not expected to open up their markets to the European Union immediately. They have transition periods of up to 15 years to remove their tariffs on EU imports, and are able to protect around 20 per cent of their products. This should allow new arrangements to be put into place before the ACP countries open their markets.

In order to be aware of any negative impacts of EPAs, the UK has pushed for appropriate mechanisms for monitoring and reviewing implementation as well as development impacts, with special attention to the most vulnerable ACP countries and communities, to be a key part of the EPA texts.

If negative impacts are found or predicted, ACP countries will be able to use the safeguard mechanisms included in EPAs. These provide for the possibility that the market access provisions can be temporarily curtailed where it can be demonstrated that there is a surge of imports and that they are causing serious injury or market disruption to either ACP or European Union suppliers.

Embryology

Lord Alton of Liverpool asked Her Majesty's Government:

The Parliamentary Under-Secretary of State, Department of Health (Lord Darzi of Denham): The Human Fertilisation and Embryology Authority (HFEA) has a policy of continuing to correct data as

17 Dec 2007 : Column WA97

new information becomes available, such as new information arising from the HFEA's historic audit

17 Dec 2007 : Column WA98

project. Revised information, including data for 2005, is shown in the table.

Total number of in vitro fertilisation (IVF) treatment cycles, embryos created and treatments resulting in live births 1991 to 2005 1
Year (calendar)Treatments involving fresh (non-frozen) embryosTreatments involving frozen embryos (2)Non-treatments (3)
Treatment cyclesEmbryos createdTreatment cycles with live birth outcomeTreatment cyclesTreatment cycles with live birth outcomeNon-Treatment cyclesEmbryos created

1991

5948

26543

822

696

105

-

-

1992

16022

75456

2114

2233

252

-

-

1993

18860

92809

2757

2939

376

-

-

1994

21345

106425

3144

3491

402

-

-

1995

24753

126078

3856

4548

542

-

-

1996

27427

148682

4764

5994

691

-

-

1997

27811

146066

4933

6178

707

-

-

1998

29078

163206

5584

6445

781

-

-

1999

28212

163840

5832

6602

844

805

575

2000

28591

170408

5982

6877

907

976

728

2001

28813

176954

6173

7416

1017

898

603

2002

29780

178627

6707

7640

1070

760

728

2003

30069

179885

6924

7449

1178

716

968

2004

32146

185581

7116

7959

1166

697

1059

2005

33591

191462

7741

8306

1313

770

1241


Next Section Back to Table of Contents Lords Hansard Home Page